Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.

Israel journal of medical sciences - 1 Oct 1997

Glauber V, Ben Abraham R, Zweig A, Perel A

Abstract excerpt

Malignant hyperthermia (MH), a rare pharmacogenetic trait, can be lethal when susceptible individuals are exposed to triggering agents during general anesthesia. We present our experience with the caffeine-halothane in vitro contracture test (IVCT) for the diagnosis of malignant hyperthermia susceptibility. Out of 75 patients that were referred for consultation to the MH diagnostic center over a period of 7...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biopsy
Share to Caffeine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Israel

Share to Muscle Contraction

Share to Muscle, Skeletal

Source

Identifiers

PMID: 9397136

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.PMID 9397136Read ↗

Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.Semantic proximity Read ↗

Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.Semantic proximity Read ↗

[Modern diagnostic approaches to malignant hyperthermia susceptibility].Semantic proximity Read ↗

European Malignant Hyperthermia Group 2025 guidelines for the investigation of malignant hyperthermia susceptibility.Semantic proximity Read ↗

[Malignant hyperthermia].Semantic proximity Read ↗

[Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].Semantic proximity Read ↗

Genetics and pathogenesis of malignant hyperthermiaSemantic proximity Read ↗

[Telephone enquiries on the topic of malignant hyperthermia: Evaluation of the content and subsequent diagnostic results at the MH Center Leipzig].Semantic proximity Read ↗

Idiopathic hyperCKemia and malignant hyperthermia susceptibility.Semantic proximity Read ↗

Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.Semantic proximity Read ↗

Molecular genetic testing for malignant hyperthermia susceptibility.Semantic proximity Read ↗

Positive Malignant Hyperthermia Susceptibility In Vitro Test in a Patient with Mitochondrial Myopathy and Myoadenylate Deaminase DeficiencySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.